In breast cancer survivors, it is encouraged to first recall non-hormonal alternatives for menopausal effects, along with bisphosphonates or selective estrogen receptor modulators (SERMs) for osteoporosis, and vaginal estrogen for local symptoms. Observational studies of systemic hormone substitute therapy after breast most cancers are usually reassuring. If hormone replacement is important after breast cancer, estrogen-best remedy or estrogen therapy with an intrauterine tool with progestogen can be safer options than mixed systemic remedy.
No comments:
Post a Comment